Inventor · disambiguated record
Matteo Biagetti
Also filed as: BIAGETTI MATTEO
11 granted patents·13 pending applications·19 citations·filing 2005–2023
84Inventor score
Top patents by PatentIndex Score
24 records- 0183US7459456B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2007·Granted Dec 2, 2008·7 cites·12 claims
- 0277US9527869B2Indolizine derivatives as phoshoinositide 3-kinases inhibitorsCHIESI FARM SPA·Filed 2015·Granted Dec 27, 2016·5 cites·21 claims
- 0374US8877774B2Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Nov 4, 2014·4 cites·21 claims
- 0472US7592346B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2008·Granted Sep 22, 2009·1 cites·25 claims
- 0570US9321776B2Isochromene derivatives as phoshoinositide 3-kinases inhibitorsCHIESI FARMA SPA·Filed 2014·Granted Apr 26, 2016·2 cites·20 claims
- 0666US7732600B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2009·Granted Jun 8, 2010·0 cites·4 claims
- 0752US2009042897A1Chemical CompoundsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 0852US2025270215A1Imidazole derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2023·Application pending·0 cites
- 0951US2010204273A1Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type ReceptorsGLAXO GROUP LTD·Filed 2010·Application pending·0 cites
- 1049US2023416233A1(aza)quinoline 4-amines derivatives as p2x3 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1148US2024025880A1Amino quinazoline derivatives as p2x3 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1247US2010286151A11-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating DisordersBENTLEY JONATHAN·Filed 2008·Application pending·0 cites
- 1347US2024116948A1Pyrido oxazine derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1444US12479826B2Pyridazinyl amino derivatives as ALK5 inhibitorsCHIESI FARM SPA·Filed 2021·Granted Nov 25, 2025·0 cites·14 claims
- 1544US2024190891A1Pyrido oxazine amino derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1643US12466820B2Amino quinazoline derivatives as P2X3 inhibitorsCHIESI FARM SPA·Filed 2020·Granted Nov 11, 2025·0 cites·9 claims
- 1742US2024116947A1Pyrido oxazine derivatives as alk5 inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1841US2010197699A1I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating DisordersGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1940US2010216821A1Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 AntagonistsBARTON NICHOLAS PAUL·Filed 2008·Application pending·0 cites
- 2038US2009203705A1Spiro Compounds As NPY Y5 Receptor AntagonistsBIAGETTI MATTEO·Filed 2009·Application pending·0 cites
- 2136US2012022056A1Fused tricyclic derivatives for the treatment of psychotic disordersBENTLEY JONATHAN·Filed 2005·Application pending·0 cites
- 2235US9968604B2Chromene derivatives as phoshoinositide 3-kinases inhibitorsCHIESI FARM SPA·Filed 2016·Granted May 15, 2018·0 cites·17 claims
- 2334US10189844B2Pyrazole derivatives as phosphoinositide 3-kinases inhibitorsCHIESI FARM SPA·Filed 2017·Granted Jan 29, 2019·0 cites·19 claims
- 2432US9745308B2Pyridazinone derivatives as phoshoinositide 3-kinases inhibitorsCHIESI FARM SPA·Filed 2015·Granted Aug 29, 2017·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Matteo Biagetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →